Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/31803| Title: | Alemtuzumab Outcomes Over 9 Years in RRMS Patients With Highly Active Disease From CARE-MS I and II (TOPAZ) | Authors: | Ziemssen, T. Bass, A. D. Berkovich, R. Eichau, S. Hobart, J. Hunter, S. F. Limmroth, V. Pelletier, D. Pozzilli, C. Schippling, S. Singer, B. A. Sousa, L. Traboulsee, A. Uittlehaag, B. M. J. VAN WIJMEERSCH, Bart Poole, E. M. Choudhry, Z. Geertsen, S. Daizadeh, N. Comi, G. |
Issue Date: | 2020 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF NEUROLOGY, 27 , p. 484 -484 | Document URI: | http://hdl.handle.net/1942/31803 | Link to publication/dataset: | https://onlinelibrary.wiley.com/doi/epdf/10.1111/ene.14307 | ISI #: | WOS:000534616801252 | Rights: | 2020 European Journal of Neurology, 27 (Suppl. 1 (Suppl. 1), 103–522 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Ziemssen_T_2020.pdf Restricted Access | Published version | 213.57 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.